ChemicalBook >> CAS DataBase List >>TocilizuMab

TocilizuMab

CAS No.
375823-41-9
Chemical Name:
TocilizuMab
Synonyms
Actemra;Atlizumab;R 1569;RoActemra;Actemra 200;TocilizuMab;Tocilizumab-Actemra;Tocilizumab,Atlizumab;anti-IL-6R Tocilizumab;Tocilizumab (anti-IL-6R)
CBNumber:
CB32735437
Molecular Formula:
C14H12O3
Molecular Weight:
0
MDL Number:
MFCD01633115
MOL File:
Mol file
Last updated:2024-07-02 08:55:06

TocilizuMab Properties

storage temp. Store at -80°C
solubility Soluble in DMSO
form Liquid
color Colorless to light yellow
FDA UNII I031V2H011
NCI Dictionary of Cancer Terms Actemra; tocilizumab
NCI Drug Dictionary Actemra
ATC code L04AC07

Pharmacokinetic data

Protein binding Not applicable
Volume of distribution 6.4 litres
Biological half-life 11-13 days (concentration dependent)

TocilizuMab price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
American Custom Chemicals Corporation ATB0023425 TOCILIZUMAB 95.00% 375823-41-9 5MG $503.02 2021-12-16 Buy
Biosynth Carbosynth BT165595 Tocilizumab 375823-41-9 1mg $600 2021-12-16 Buy
ChemScene CS-0028521 Tocilizumab 99.67% 375823-41-9 5mg $670 2021-12-16 Buy
ChemScene CS-0028521 Tocilizumab 99.67% 375823-41-9 1mg $280 2021-12-16 Buy
ChemScene CS-0028521 Tocilizumab 99.67% 375823-41-9 25mg $2500 2021-12-16 Buy
Product number Packaging Price Buy
ATB0023425 5MG $503.02 Buy
BT165595 1mg $600 Buy
CS-0028521 5mg $670 Buy
CS-0028521 1mg $280 Buy
CS-0028521 25mg $2500 Buy

TocilizuMab Chemical Properties,Uses,Production

Clinical Use

Interleukin inhibitor:
Treatment of rheumatoid arthritis in combination with methotrexate

Drug interactions

Potentially hazardous interactions with other drugs
Live vaccines: avoid concomitant administration

Metabolism

Tocilizumab undergoes biphasic elimination from the circulation. The total clearance of tocilizumab is concentration-dependent and is the sum of the linear and non-linear clearance. The concentration-dependent non-linear clearance plays a major role at low tocilizumab concentrations. Once the non-linear clearance pathway is saturated, at higher tocilizumab concentrations, clearance is mainly determined by the linear clearance.

TocilizuMab Preparation Products And Raw materials

Raw materials

Preparation Products

TocilizuMab Suppliers

Global( 83)Suppliers
Supplier Tel Email Country ProdList Advantage
Hangzhou FandaChem Co.,Ltd.
+8615858145714 FandaChem@Gmail.com China 9206 55
Hebei Weibang Biotechnology Co., Ltd
+8615531157085 abby@weibangbio.com China 8810 58
Career Henan Chemica Co
+86-0371-86658258 +8613203830695 laboratory@coreychem.com China 30240 58
Shanghai Minbiotech Co., Ltd.
+8617315815539 sales@minbiotech.com CHINA 129 58
AFINE CHEMICALS LIMITED
+86-0571-85134551 sales@afinechem.com China 15352 58
Wuhan Fortuna Chemical Co., Ltd
+86-027-59207850 info@fortunachem.com China 5978 58
Hefei Hirisun Pharmatech Co., Ltd
+8615056975894 shawn@hirisunpharm.com CHINA 9911 58
Guangzhou TongYi biochemistry technology Co.,LTD
+8613073028829 mack@tongyon.com China 2994 58
Hebei Fengjia New Material Co., Ltd
+86-0311-87836622 +86-17333973358 sales06@hbduling.cn China 8053 58
TargetMol Chemicals Inc.
support@targetmol.com United States 38632 58

View Lastest Price from TocilizuMab manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Tocilizumab pictures 2024-11-27 Tocilizumab
375823-41-9
US $0.00-0.00 / g 1g 99% 100G WUHAN FORTUNA CHEMICAL CO., LTD
TocilizuMab pictures 2024-09-25 TocilizuMab
375823-41-9
US $0.00 / g 1g 99% 50kg Wuhan Senwayer Century Chemical Co.,Ltd
TocilizuMab pictures 2021-11-20 TocilizuMab
375823-41-9
US $10.00 / KG 100KG 99% 100 mt Hebei Weibang Biotechnology Co., Ltd
  • Tocilizumab pictures
  • Tocilizumab
    375823-41-9
  • US $0.00-0.00 / g
  • 99%
  • WUHAN FORTUNA CHEMICAL CO., LTD
  • TocilizuMab pictures
  • TocilizuMab
    375823-41-9
  • US $0.00 / g
  • 99%
  • Wuhan Senwayer Century Chemical Co.,Ltd
  • TocilizuMab pictures
  • TocilizuMab
    375823-41-9
  • US $10.00 / KG
  • 99%
  • Hebei Weibang Biotechnology Co., Ltd
TocilizuMab Actemra 200 R 1569 RoActemra Tocilizumab,Atlizumab anti-IL-6R Tocilizumab Tocilizumab (anti-IL-6R) Tocilizumab-Actemra Actemra Atlizumab Research Grade Tocilizumab(DHC36902) COVID-19,IL-6R,Anti-Human IL6R, Humanized Antibody,rheumatoid,respiratory failure,antibody,Interleukin Related,coronavirus disease,Tocilizumab,arthritis,inhibit,dyspnoea,Neutralizing,Inhibitor 375823-41-9 API